$483 Million is the total value of Welch Group, LLC's 143 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 6.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
LMT | Sell | Lockheed Martin Corp | $14,848,000 | -4.8% | 92,380 | -3.3% | 3.08% | -12.9% |
MMM | Sell | 3m Company | $14,179,000 | +5.0% | 98,988 | -0.5% | 2.94% | -4.0% |
UTX | Sell | United Technologies Corp | $13,792,000 | -1.2% | 119,460 | -0.0% | 2.86% | -9.7% |
RDSB | Sell | Royal Dutch Shell B Adrf | $5,421,000 | +11.2% | 62,303 | -0.1% | 1.12% | +1.7% |
EGN | Sell | Energen Corp | $4,969,000 | +7.0% | 55,905 | -2.7% | 1.03% | -2.2% |
UN | Sell | Unilever N V Ny Shs Newf | $2,501,000 | +6.2% | 57,142 | -0.2% | 0.52% | -2.8% |
TMK | Sell | Torchmark Corporation | $2,497,000 | +3.0% | 30,479 | -1.0% | 0.52% | -5.8% |
VEA | Sell | Vanguard Msci Eafe Etf | $2,441,000 | +1.8% | 57,307 | -1.3% | 0.50% | -7.0% |
PL | Sell | Protective Life Corp | $1,898,000 | +30.8% | 27,372 | -0.8% | 0.39% | +19.5% |
Sell | Berkshire Hathaway Cl B | $1,419,000 | +0.5% | 11,215 | -0.8% | 0.29% | -8.1% | |
MRK | Sell | Merck & Co Inc | $1,049,000 | +1.1% | 18,128 | -0.9% | 0.22% | -7.7% |
CAT | Sell | Caterpillar Inc | $971,000 | +8.5% | 8,935 | -0.8% | 0.20% | -1.0% |
RF | Sell | Regions Financial Cp New | $866,000 | -4.5% | 81,571 | -0.1% | 0.18% | -12.7% |
SNV | Sell | Synovus Financial Corp | $850,000 | +2.8% | 34,848 | -85.7% | 0.18% | -5.9% |
IBM | Sell | Intl Business Machines | $791,000 | -6.4% | 4,361 | -0.7% | 0.16% | -14.1% |
SLB | Sell | Schlumberger Ltd | $792,000 | +19.5% | 6,715 | -1.2% | 0.16% | +9.3% |
KRFT | Sell | Kraft Foods Group | $607,000 | +5.6% | 10,119 | -1.2% | 0.13% | -3.1% |
RY | Sell | Royal Bk Cda Montreal | $484,000 | +6.8% | 6,776 | -1.2% | 0.10% | -2.9% |
GE | Sell | General Electric Company | $469,000 | +0.2% | 17,833 | -1.4% | 0.10% | -8.5% |
SYK | Sell | Stryker Corp | $350,000 | +2.3% | 4,156 | -1.0% | 0.07% | -6.5% |
GOOGL | Sell | Google Inc Class A | $269,000 | -50.4% | 460 | -5.3% | 0.06% | -54.5% |
GILD | Sell | Gilead Sciences Inc | $259,000 | +15.6% | 3,118 | -1.3% | 0.05% | +5.9% |
Sell | Albemarle Corp | $217,000 | -16.5% | 3,041 | -22.4% | 0.04% | -23.7% | |
ORCL | Sell | Oracle Corporation | $214,000 | -2.7% | 5,284 | -1.7% | 0.04% | -12.0% |
ESRX | Sell | Express Scripts Inc | $209,000 | -34.1% | 3,014 | -28.6% | 0.04% | -40.3% |
QCOM | Sell | Qualcomm Inc | $199,000 | 0.0% | 2,509 | -0.6% | 0.04% | -8.9% |
CLB | Sell | Core Laboratories N V | $167,000 | -27.4% | 998 | -13.7% | 0.04% | -32.7% |
NSC | Sell | Norfolk Southern Corp | $138,000 | -1.4% | 1,337 | -7.3% | 0.03% | -9.4% |
Sell | Bank Of America Corp | $135,000 | -13.5% | 8,752 | -3.2% | 0.03% | -20.0% | |
Exit | Beam Inc | $0 | – | -2,000 | -100.0% | -0.04% | – | |
MINT | Exit | Pimco Exch Traded Fund | $0 | – | -21,182 | -100.0% | -0.49% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-07-22
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Abbvie Inc Com USD0.01 | 42 | Q3 2023 | 3.8% |
NEXTERA ENERGY INC | 42 | Q3 2023 | 3.6% |
LOCKHEED MARTIN CORP | 42 | Q3 2023 | 3.5% |
The Southern Company | 42 | Q3 2023 | 3.5% |
GALLAGHER ARTHUR J & CO | 42 | Q3 2023 | 3.5% |
Pepsico Incorporated | 42 | Q3 2023 | 3.2% |
Exxon Mobil Corporation | 42 | Q3 2023 | 3.7% |
Chevron Corporation | 42 | Q3 2023 | 3.7% |
MCDONALDS CORP | 42 | Q3 2023 | 3.5% |
JOHNSON & JOHNSON | 42 | Q3 2023 | 3.3% |
View Welch Group, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-09 |
13F-HR | 2024-01-23 |
13F-HR | 2023-10-18 |
13F-HR | 2023-07-18 |
13F-HR | 2023-04-13 |
13F-HR | 2023-01-30 |
13F-HR | 2022-10-13 |
13F-HR | 2022-07-21 |
13F-HR | 2022-04-29 |
13F-HR | 2022-01-26 |
View Welch Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.